• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Bausch + Lomb Corporation Common Shares (NY:BLCO)

    13.53 -0.20 (-1.46%)
    Streaming Delayed Price Updated: 11:24 AM EDT, Apr 28, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Bausch + Lomb Corporation Common Shares

    < Previous 1 2 3 4 Next >
    Bausch + Lomb Returning enVista® Intraocular Lenses to Market Following Voluntary Recall
    From Bausch + Lomb Corporation
    Via Business Wire
    Bausch + Lomb Announces Voluntary Recall of enVista Aspire™, enVista Envy™ and Certain enVista® Monofocal Intraocular Lenses
    From Bausch + Lomb Corporation
    Via Business Wire
    Bausch + Lomb Will Release First-Quarter 2025 Financial Results on April 30
    From Bausch + Lomb Corporation
    Via Business Wire
    Bausch + Lomb Launches Arise™ Orthokeratology Lens System in the United States
    From Bausch + Lomb Corporation
    Via Business Wire
    Bausch + Lomb Announces Fourth-Quarter and Full-Year 2024 Results, Provides 2025 Guidance
    From Bausch + Lomb Corporation
    Via Business Wire
    Bausch + Lomb Provides Update on Potential Sale
    From Bausch + Lomb Corporation
    Via Business Wire
    Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2024 Financial Results on February 19
    From Bausch + Lomb Corporation
    Via Business Wire
    Bausch + Lomb Bolsters Pipeline with Acquisition of Whitecap Biosciences
    From Bausch + Lomb Corporation
    Via Business Wire
    Bausch + Lomb Launches enVista Aspire™ Intermediate Optimized Monofocal and Toric Intraocular Lenses in the European Union
    From Bausch + Lomb Corporation
    Via Business Wire
    Bausch + Lomb and Glaucoma Research Foundation Launch Second Annual “Faces of Glaucoma” Campaign and Fundraising Challenge
    From Bausch + Lomb Corporation
    Via Business Wire
    Bausch + Lomb to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
    From Bausch + Lomb Corporation
    Via Business Wire
    Bausch + Lomb Responds to Rumors of a Potential Sale
    From Bausch + Lomb Corporation
    Via Business Wire
    Bausch + Lomb Acquires Elios Vision, Significantly Enhances Glaucoma Treatment Capabilities
    From Bausch + Lomb Corporation
    Via Business Wire
    Bausch + Lomb Reports More Than 94 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs
    From Bausch + Lomb Corporation
    Via Business Wire
    Bausch + Lomb Announces Third-Quarter 2024 Results
    From Bausch + Lomb Corporation
    Via Business Wire
    Bausch + Lomb Receives FDA Approval for enVista® Envy™ Full Range of Vision Intraocular Lens
    From Bausch + Lomb Corporation
    Via Business Wire
    Bausch + Lomb Will Release Third-Quarter 2024 Financial Results on October 30
    From Bausch + Lomb Corporation
    Via Business Wire
    Bausch + Lomb Launches Opal™ Digital Marketplace in the United States
    From Bausch + Lomb Corporation
    Via Business Wire
    Bausch Health: A Buyout Bid Could Be the Ticket to Unlock Value
    The potential sale of Bausch + Lomb, Bausch Health's eye care business, could result in a financial gain for the company by reducing its debt burden. 
    Via MarketBeat
    Bausch + Lomb Announces Second-Quarter 2024 Results
    From Bausch + Lomb Corporation
    Via Business Wire
    Bausch + Lomb Will Release Second-Quarter 2024 Financial Results on July 31
    From Bausch + Lomb Corporation
    Via Business Wire
    Millions of Americans Experience Dry Eye Symptoms, Yet New National Survey Shows Sufferers Struggle to Find Relief
    From Bausch + Lomb Corporation
    Via Business Wire
    Bausch + Lomb Announces Presentation of New Data at the European Dry Eye Society 2024 Congress
    From Bausch + Lomb Corporation
    Via Business Wire
    Bausch + Lomb INFUSE® for Astigmatism Silicone Hydrogel Daily Disposable Contact Lenses Introduced in the United States
    From Bausch + Lomb Corporation
    Via Business Wire
    Bausch + Lomb Launches Blink™ NutriTears® Clinically Proven Nutritional Supplement for Dry Eyes in the United States
    From Bausch + Lomb Corporation
    Via Business Wire
    Bausch + Lomb Announces 2024 Annual Meeting of Shareholder Results
    From Bausch + Lomb Corporation
    Via Business Wire
    Bausch + Lomb Announces Presentation of New Scientific Data and Evaluations Featuring Consumer, Vision Care and Pharmaceutical Products at Optometry’s Meeting®
    From Bausch + Lomb Corporation
    Via Business Wire
    Bausch + Lomb Receives Health Canada Approval for enVista® Envy™* Full Visual Range Intraocular Lens
    From Bausch + Lomb Corporation
    Via Business Wire
    Bausch + Lomb Announces First-Quarter 2024 Results
    From Bausch + Lomb Corporation
    Via Business Wire
    Bausch + Lomb Announces Presentation of New Data at the Association for Research in Vision and Ophthalmology Annual Meeting
    From Bausch + Lomb Corporation
    Via Business Wire
    < Previous 1 2 3 4 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.